arrow
S

Sara Ghorashian

ucl great ormond street institute of child health
H指数:28
被引数:4,686

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tisagenlecleucel for post-transplant relapse in young acute lymphoblastic leukemia patients: European real-world determinants of outcome
Leukemia
IF13.4
2026-08-310
OA
Plasticity under pressure: biology and detection of lineage switch in acute leukemia

压力下的可塑性:急性白血细胞系的生物学及转换检测

Leukemia
IF13.4
2026-06-260
PRE
Harmonization on defining B-cell recovery post CD19-CAR T-cell therapy in B-cell acute lymphoblastic leukemia: An international consensus statement

关于CD19-CAR T细胞疗法后B细胞恢复定义的标准化:一项国际共识声明

2025-11-120
OAAI
Position statement from the British Society of Blood and Marrow Transplantation and Cellular Therapy on insertional oncogenesis in gene-engineered advanced cell therapy products for treatment of haematological disorders

英国血液与骨髓移植及细胞治疗学会关于基因工程化高级细胞治疗产品在血液系统疾病治疗中插入性致癌作用的立场声明

2025-11-010
OAAI
International consensus guidelines for the conduct and reporting of CAR T-cell clinical trials in AML

国际共识指南:关于AML CAR T细胞临床研究的实施与报告

2025-08-210
OAAI
Setting up a Chimeric Antigen Receptor T Cell Therapy Program: A Framework for Delivery from the Worldwide Network for Blood & Marrow Transplantation

建立嵌合抗原受体T细胞疗法项目:世界造血与骨髓移植网络交付框架

2025-05-230
PRE
Risk factors for CAR T-cell manufacturing failure and patient outcomes in large B-cell lymphoma: a report from the UK National CAR T Panel

CAR T细胞制备失败的风险因素及大B细胞淋巴瘤患者结局:英国国家CAR T小组报告

2025-03-042
OA
Whole genome sequencing provides practice-changing benefits when performed on consecutive, unselected children with suspected cancer
2024-09-050
PRE
Benefits for children with suspected cancer from routine whole-genome sequencing
2024-07-025
OAAI
Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapy
2024-04-155
OAAI
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access scheme
2024-04-150
OAAI
Transcriptional signatures associated with persisting CD19 CAR-T cells in children with leukemia

与白血病儿童中持续存在的CD19 car-t细胞相关的转录特征

2023-07-0623
OAAI
Activation priming and cytokine polyfunctionality modulate the enhanced functionality of low-affinity CD19 CAR T cells

激活引发和细胞因子多功能性调节低亲和力CD19 CAR T细胞的增强功能

2023-04-2713
OAAI
Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort study

Tisagenlecleucel治疗3岁以下婴儿和儿童复发或难治性急性淋巴细胞白血病: 一项国际、多中心、回顾性队列研究

2022-10-0128
OAAI
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study

CD19 car-t细胞治疗儿童复发性急性淋巴细胞白血病伴中枢神经系统受累: 一项回顾性国际研究

LEUKEMIA
IF13.4
2022-04-2535
PRE
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial

儿童和年轻成人复发或难治性b细胞急性淋巴细胞白血病患者中CD19和CD22双重靶向的CAR T细胞: 1期试验

2021-10-12163
OAAI